Results 91 to 100 of about 136,887 (323)

Diagnostic Approach for Suspected Acute Myocarditis: Considerations for Standardization and Broadening Clinical Spectrum

Journal of the American Heart Association : Cardiovascular and Cerebrovascular Disease, 2023
Myocarditis is most recognized in patients with moderate to severe, recent‐onset heart failure. However, less typical presentations including myocardial infarction with normal coronary arteries and arrhythmias are important manifestations but less ...
Pieter Martens, L. Cooper, W. Tang
semanticscholar   +1 more source

Genetic Architecture of Acute Myocarditis and the Overlap With Inherited Cardiomyopathy

Circulation, 2022
Background: Acute myocarditis is an inflammatory condition that may herald the onset of dilated cardiomyopathy (DCM) or arrhythmogenic cardiomyopathy (ACM).
A. Lota, M. Hazebroek, P. Theotokis, R. Wassall, Sara Salmi, B. Halliday, U. Tayal, J. Verdonschot, D. Meena, R. Owen, A. de Marvao, A. Iacob, M. Yazdani, D. Hammersley, Richard E Jones, R. Wage, R. Buchan, Fredrik Vivian, Y. Hafouda, M. Noseda, J. Gregson, T. Mittal, J. Wong, J. Robertus, A. Baksi, V. Vassiliou, I. Tzoulaki, A. Pantazis, J. Cleland, P. Barton, S. Cook, D. Pennell, P. García-Pavía, L. Cooper, S. Heymans, J. Ware, S. Prasad   +36 more
semanticscholar   +1 more source

Viral myocarditis [PDF]

Current Opinion in Rheumatology, 2016
Purpose of review The article traces the pathways leading from viral infection of the heart by coxsackievirus B3 to autoimmune myocarditis in its various manifestations. Recent findings Myocarditis can be induced by a number of different infectious agents and represents a ...
openaire   +2 more sources

A Novel Clinical Score for Differential Diagnosis Between Acute Myocarditis and Acute Coronary Syndrome – The SAlzburg MYocarditis (SAMY) Score

Frontiers in Medicine, 2022
BackgroundAcute myocarditis and acute coronary syndrome (ACS) are important differential diagnoses in patients with new-onset chest pain. To date, no clinical score exists to support the differentiation between these two diseases.
Moritz Mirna, Lukas Schmutzler, Albert Topf, Brigitte Sipos, Lukas Hehenwarter, Uta C. Hoppe, Michael Lichtenauer   +6 more
doaj   +1 more source

Long‐Term Outcomes of Reduced Intensity Conditioning Hematopoietic Stem Cell Transplantation for Systemic Sclerosis Patients with Impaired Cardiac Function

Arthritis &Rheumatology, Accepted Article.
Objective High intensity conditioning autologous hematopoietic stem cell transplantation (AHSCT) is standard of care for patients with advanced SSc. The role of reduced intensity conditioning (RIC) prior to AHSCT in this population remains unclear. We conducted this study to determine the long‐term outcomes of RIC AHSCT in SSc patients with cardiac ...
Yonatan Lean, Carrie Richardson, Anthony Esposito, Katy Bedjeti, George E. Georges   +4 more
wiley   +1 more source

Pediatric Myocarditis

Cardiology and Therapy, 2023
Myocarditis is a condition caused by acute or chronic inflammation of the cardiac myocytes, resulting in associated myocardial edema and myocardial injury or necrosis.
Jason L. Williams, Hannah M. Jacobs, Simon Lee   +2 more
semanticscholar   +1 more source

Myocarditis Caused by Human Parechovirus in Adult

Emerging Infectious Diseases, 2017
The infectious etiology of myocarditis often remains unidentified. We report a case of myocarditis associated with human parechovirus (HPeV) infection in an adult.
Khai Lin Kong, Jillian S.Y. Lau, Su Mei Goh, Heather L. Wilson, Mike Catton, Tony M. Korman   +5 more
doaj   +1 more source

A systematic review of myasthenia gravis complicated with myocarditis

Brain and Behavior, 2021
Among many of the autoimmune diseases observed in patients with myasthenia gravis (MG), myocarditis is one of the most critical. The goal of this review is to systematically describe and investigate the characteristics of MG complicated with myocarditis.
Wei Cheng, Tian Sun, Cong Liu, Zijing Zhou, Jiaxi Duan, Yiyang Zhao, Min Yang, Ping Chen   +7 more
doaj   +1 more source

Electrocardiographic features of immune checkpoint inhibitor associated myocarditis

Journal for ImmunoTherapy of Cancer, 2021
Background Myocarditis is a highly morbid complication of immune checkpoint inhibitor (ICI) use that remains inadequately characterized. The QRS duration and the QTc interval are standardized electrocardiographic measures that are prolonged in other ...
Anju Nohria, Alexander R Lyon, Stephane Ederhy, Franck Thuny, Michael Mahmoudi, Magid Awadalla, Dahlia Banerji, Merna Armanious, Dipti Gupta, Sarju Ganatra, Paaladinesh Thavendiranathan, Gagan Sahni, Ryan Sullivan, Lili Zhang, Tomas G Neilan, Daniel A Zlotoff, Malek Z O Hassan, Amna Zafar, Raza M Alvi, Syed S Mahmood, Carol L Chen, Ana Barac, Maeve Jones-O'Connor, Sean P Murphy, Brian J Forrestal, Michael C Kirchberger, Otavio R Coelho-Filho, Muhammad A Rizvi, Anant Mandawat, Carlo G Tocchetti, Sarah Hartmann, Hannah K Gilman, Eduardo Zatarain-Nicolás, Lucie M Heinzerling, Justine V Cohen, John Groarke, Michael G Fradley   +36 more
doaj   +1 more source

Clinical Safety of Extended Interval Dosing of Nivolumab in Patients with Melanoma

Clinical Pharmacology &Therapeutics, EarlyView.
Extended interval dosing regimens of immune checkpoint inhibitors have been implemented widely. However, their approval was mainly based on pharmacokinetic modeling and simulations. Consequently, comparative safety data of extended interval dosing regimens in a real‐world setting are limited.
Ruben Malmberg, Maaike M. Hofman, Fatima Ashad, Alaa Daloul, Stefani Oosterveld, Edwin A. Basak, Esther Oomen‐de Hoop, Astrid A. M. van der Veldt, Arjen Joosse, Roelof W. F. van Leeuwen, Ron H. J. Mathijssen   +10 more
wiley   +1 more source